Total planned funding: $730,822,223
Clear active filters
HTXD: Treatment: ARV Drugs
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Nigeria | $151,713,825 |
Zambia | $97,100,721 |
Uganda | $88,694,467 |
Tanzania | $85,668,596 |
Kenya | $75,727,670 |
Mozambique | $66,362,003 |
Zimbabwe | $40,376,916 |
Côte d'Ivoire | $31,308,432 |
Rwanda | $21,470,342 |
Haiti | $18,178,003 |
Vietnam | $17,598,765 |
Democratic Republic of the Congo | $13,705,154 |
South Africa | $8,401,481 |
Eswatini | $6,040,866 |
Botswana | $4,824,141 |
Ukraine | $2,631,114 |
Guyana | $640,000 |
South Sudan | $80,453 |
Burundi | $54,720 |
Cambodia | $50,217 |
Dominican Republic | $48,986 |
Ethiopia | $46,898 |
Papua New Guinea | $35,833 |
Central Asia Region | $33,169 |
Cameroon | $27,160 |
Caribbean Region | $2,291 |
Organizational Types
Private Contractor | $575,806,856 |
Host Country Government Agency | $71,415,222 |
NGO | $64,400,848 |
Unknown | $16,092,478 |
Own Agency | $1,346,955 |
Implementing Agency | $906,213 |
Other USG Agency | $569,897 |
University | $147,054 |
FBO | $136,700 |
Program Areas
Treatment | $730,822,223 |
Budget Codes
HTXD: Treatment: ARV Drugs | $730,822,223 |
Top Partner Programs
Medical Access Uganda Limited:
$57,708,069
View countries